Remove Containment Remove Life Science Remove Production
article thumbnail

Attorney Tope Leyimu Discusses Proposed FDA ban on Hair Relaxer Products Containing Harmful Chemicals – Xtalks Life Science Podcast Ep. 137

XTalks

This episode features an interview with Attorney Temitope (Tope) Leyimu, a toxic exposure attorney at Motley Rice who is leading a lawsuit over hair relaxing products that contain harmful chemicals. The FDA recently issued a recommendation for the recall of chemical hair relaxers containing harmful chemicals. Temitope (Tope) O.

article thumbnail

Pharmaceutical Equipment Manufacturer Unveils Custom Wash Rack Services 

Pharma Mirror

North Charleston, SC: Pharmaceutical sterilization and cleaning equipment manufacturer Belimed Life Science, North Charleston, SC, has unveiled custom wash rack design and manufacturing services.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BioNTech Unveils the BioNTainer, a Modular mRNA Vaccine Factory to Help Production in Africa

XTalks

BioNTech announced its new vaccine manufacturing approach in Africa where the company will ship modular factories, called the BioNTainer, to the continent to enable domestic production of the vaccines to help increase supplies. Related: BioNTech to Build First mRNA Vaccine Production Plant in Africa. Photo source: BioNTech.

Vaccine 105
article thumbnail

Walgreens, CVS Among Companies Issued FDA Warning Letters Over Unapproved Eye Products

XTalks

The US Food and Drug Administration (FDA) has issued warning letters to eight companies manufacturing or marketing unapproved eye products that violate federal law. The FDA said the warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products.

article thumbnail

Targeting AML with New Generation T-Cell Therapies – Xtalks Life Science Podcast Ep. 162

XTalks

Tune into the episode to learn about CERo’s next-gen T-cell technology and its lead therapeutic candidate, a CER T cell product that contains a phagocyte receptor component. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

Allogeneic therapies begin with healthy donor samples to develop the eventual therapeutic product which can be administered to multiple patients. CGT trials operate with much lower volumes of manufactured final product. The labeling process of the final product is earlier than that for traditional trials.

article thumbnail

Expert Insights: Development and Manufacture of Highly Potent Oral Liquids

XTalks

In 2020, the US Food and Drug Administration (FDA) issued a Guidance for Industry recommending that sponsors include plans for developing age-appropriate formulations of drug products in instances where adult formulations may not be suitable for paediatric patients. One of the most significant benefits of PDFs is their ease of administration.